Context Therapeutics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Context Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- CNTX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001842952
Board of directors
-
Andy Pasternak · DirectorSince 2025
-
Jennifer Evans Stacey · DirectorSince 2023
-
Karen L. Smith · DirectorSince 2024
-
Linda West · DirectorSince 2023
-
Luke Nathaniel Walker · DirectorSince 2024
-
Martin A. Lehr · Director · Chief Executive OfficerSince 2023
-
Philip W. Kantoff · DirectorSince 2023
- Since 2023
Chief executives
Martin A. Lehr
· Chief Executive Officer
Dates unknown
Board connections
3 of this board's directors also sit on 7 other boards.
- via Karen L. Smith
- via Richard J. Berman
- via Richard J. Berman
- via Richard J. Berman
- via Richard J. Berman
- via Karen L. Smith
- via Luke Nathaniel Walker
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 9, 2025 | Martin A. Lehr Director, Officer (Chief Executive Officer) | Open-market purchase | +100,000 | $0.70 | $70,000 |
| Jun 6, 2025 | Levit Alex C. Officer (Chief Legal Officer, Corp. Sec) | Open-market purchase | +20,000 | $0.58 | $11,600 |
| Jun 6, 2025 | Minai-Azary Jennifer Lynn Officer (Chief Financial Officer) | Open-market purchase | +40,010 | $0.64 | $25,606 |
| Feb 21, 2023 | Martin A. Lehr Director, Officer (Chief Executive Officer) | Open-market purchase | +5,823 | $0.84 | $4,891 |
| Feb 13, 2023 | Martin A. Lehr Director, Officer (Chief Executive Officer) | Open-market purchase | +5,606 | $0.87 | $4,877 |
| Feb 6, 2023 | Martin A. Lehr Director, Officer (Chief Executive Officer) | Open-market purchase | +5,040 | $0.97 | $4,889 |
| Jan 30, 2023 | Martin A. Lehr Director, Officer (Chief Executive Officer) | Open-market purchase | +7,027 | $0.70 | $4,919 |
| Jan 23, 2023 | Martin A. Lehr Director, Officer (Chief Executive Officer) | Open-market purchase | +6,839 | $0.72 | $4,924 |
| Jan 17, 2023 | Martin A. Lehr Director, Officer (Chief Executive Officer) | Open-market purchase | +6,783 | $0.74 | $5,019 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.